Follistatin: Handling, Storage, and Reconstitution Guide

Follistatin is a research-grade glycoprotein, a protein with sugar chains attached. As a protein, it needs handling that keeps its structure and activity intact. This guide covers lab best practices for Follistatin storage, reconstitution, and records. It is framed for in-vitro and animal-model prep only. It is not human-use guidance.

How should Follistatin be stored?

Store the sealed vial of freeze-dried Follistatin at or below minus 20 degrees Celsius. Keep it away from heat, light, and moisture.

Proper storage starts with the freeze-dried, or lyophilized, powder. Keeping it frozen and dry limits two kinds of damage before the vial is opened. One is hydrolysis, breakdown by water. The other is oxidation.

Glycoproteins are more sensitive than small synthetic peptides. So a strict cold chain is central to repeatable results. Labs check freezer temperature logs. They record storage conditions as part of quality control. Then any lapse can be linked to later changes in assay behavior. The same care supports the repeatable results in our Follistatin research applications overview.

How to reconstitute Follistatin gently

Follistatin is reconstituted using standard protein-handling rules. The key is to avoid mechanical stress.

For in-vitro prep, the steps are:

1. Add a suitable sterile solvent slowly down the inside wall of the vial.
2. Do not add it directly onto the powder. This lets the protein dissolve without too much shear.
3. Swirl the vial gently.
4. Do not vortex or shake. Mechanical stress can unfold (denature) the protein or make it clump.

Once dissolved, follistatin is less stable than in its freeze-dried state. So batches are used or split into portions quickly. The dissolved material is kept in the fridge. Labs also keep freeze-thaw cycles to a minimum, because repeated freezing can reduce protein activity.

These prep choices directly affect the results in the Follistatin mechanism of action overview.

• Add solvent slowly along the vial wall
• Swirl gently, do not vortex
• Keep reconstituted material refrigerated
• Minimize freeze-thaw cycles

How to aliquot Follistatin to protect activity

Aliquoting is the standard way to protect follistatin. Freeze-thaw cycles are a main cause of lost activity.

After reconstitution, the solution is split into single-use portions, called aliquots. Their size matches the study design. Each experiment then draws from a fresh aliquot. No single stock is thawed again and again.

Aliquots are labeled with lot number, strength, and date. They are stored under validated conditions. This protects the glycoprotein. It also creates a clear chain of custody for each portion used.

For a protein reagent, the number of freeze-thaw cycles it can tolerate is worth testing directly. Some labs run a small stability check. They compare activity in a set assay after one, two, and three cycles. Then they set a limit based on evidence for their own batch, rather than a generic guess. Recording that limit with the lot record keeps later handling choices consistent.

What batch records and isoform details matter for Follistatin?

Follistatin quality records reflect its nature as a protein. Each batch ships with:

• Purity testing suited to a glycoprotein, such as SDS-PAGE and reverse-phase HPLC.
• Identity confirmation.
• Lot number, test date, and method details.

Sugar chains can vary between batches. This batch-level testing supports repeatable results across experiments.

Researchers can request sample records before purchase to confirm test details. Labs are also encouraged to run their own checks suited to work with recombinant or purified proteins.

The specific isoform is worth recording with the lot data. It affects the apparent molecular weight, which falls in the range of about 34.8 to 38 kDa. The growth-factor reagents in the IGF-1 LR3 handling guide carry their own testing notes in the same way.

How to verify a Follistatin COA and lot

A good check links the paperwork to the physical vial. On arrival, teams:

1. Compare the certificate or records against the vial label.
2. Enter the lot number in their inventory system.
3. File the records for audits.

Handling steps, storage conditions, and reconstitution details are all logged. That way, data can be traced back to one batch.

This is the same traceability standard used for other growth-axis reagents. One example is the practice in the Tesamorelin handling guide. Consistent records are what let results from different studies be compared with confidence.

How is Follistatin supplied?

Follistatin is supplied as a 1 mg lyophilized research vial for lab use. Keeping the material intact is the practical base for repeatable data. That runs from cold-chain receipt, through gentle reconstitution, to careful aliquoting.

Handled with these protein-specific precautions, follistatin stays a reliable blocking reagent. It serves well across muscle biology and growth-factor studies.

What are common Follistatin handling mistakes?

A few avoidable errors cause most activity loss in protein reagents.

Surface loss. Protein sticks to plastic and glass. This can lower the real strength of dilute follistatin solutions. So labs often make working dilutions in buffer with an added carrier protein. They also use low-retention labware when suitable.

Foaming. Foam during reconstitution is a warning sign. The surface where air meets liquid promotes protein unfolding.

Temperature swings. These are the other common cause. Examples include:

• Leaving dissolved material at room temperature.
• Refreezing thawed aliquots.
• Storing the freeze-dried vial in a frost-free freezer that warms during defrost cycles.

Each of these can reduce activity in ways that only show up later as uneven assay results. Logging each handling step against the lot record helps teams tell material problems from test problems. That strengthens the traceability linking handling to repeatable mechanism and application data.

For research use only. Not for human or veterinary use. All statements describe reported findings in preclinical and in-vitro research models and are provided for laboratory reference only.